Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)
US9339556B2 · kind B2 · utility
9Cited by
7References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2013 |
| Grant date | May 17, 2016 |
| Priority date | — |
| Expiry date | Aug 16, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes compositions and methods for targeting the LOX-1 receptor on immune cells and uses for the anti-LOX-1 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.